Activin A maintains pluripotency markers and proliferative potential of human induced pluripotent stem cells

Experimental and Therapeutic Medicine

Volumn 2, Issue 3, 2011, Pages 405-408

  Tomizawa, Minoru ^a   Shinozaki, Fuminobu ^a   Sugiyama, Takao ^a   Yamamoto, Shigenori ^a   Sueishi, Makoto ^a   Yoshida, Takanobu ^a  

^a SHIMOSHIZU HOSPITAL   (Japan)

Author keywords

Alkaline phosphatase staining; Embryoid body; Feederfree culture

Indexed keywords

ACTIVIN A; ALKALINE PHOSPHATASE; MATRIGEL;

ARTICLE; CELL CULTURE; CELL PROLIFERATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PLURIPOTENT STEM CELL;

EID: 79953271201     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2011.219     Document Type: Article

References (15)

1. Sulzbacher S, Schroeder IS, Truong TT and Wobus AM: Activin A-induced differentiation of embryonic stem cells into endoderm and pancreatic progenitors-the influence of differentiation factors and culture conditions. Stem cell Rev 5: 159-173, 2009.
2. Smith JC, Price BM, van Nimmen K and Huylebroeck D: Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A. Nature 345: 729-731, 1990.
3. Thomsen G, Woolf T, Whitman M, et al: Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures. Cell 63: 485-493, 1990.
4. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E and Baetge EE: Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23: 1534-1541, 2005.
5. Yao S, Chen S, Clark J, et al: Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc Natl Acad Sci USA 103: 6907-6912, 2006.
6. Xiao L, Yuan X and Sharkis SJ: Activin A maintains self-renewal and regulates fibroblast growth factor, Wnt, and bone morphogenic protein pathways in human embryonic stem cells. Stem cells 24: 1476-1486, 2006.
7. Touboul T, Hannan NR, Corbineau S, et al: Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 51: 1754-1765, 2010.
8. Tomizawa M, Toyama Y, Ito C, et al: Hepatoblast-like cells enriched from mouse embryonic stem cells in medium without glucose, pyruvate, arginine, and tyrosine. Cell Tissue Res 333: 17-27, 2008.
9. Basma H, Soto-Gutierrez A, Yannam GR, et al: Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology 136: 990-999, 2009.
10. Vallier L, Touboul T, Brown S, et al: Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem cells 27: 2655-2666, 2009.
11. Beattie GM, Lopez AD, Bucay N, et al: Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem cells 23: 489-495, 2005.
12. Sato N, Meijer L, Skaltsounis L, Greengard P and Hemmati-Brivanlou A: Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 10: 55-63, 2004.
13. James D, Levine AJ, Besser D and Hemmati-Brivanlou A: TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132: 1273-1282, 2005.
14. Vallier L, Mendjan S, Brown S, et al: Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 136: 1339-1349, 2009.
15. Vallier L, Alexander M and Pedersen RA: Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J cell Sci 118: 4495-4509, 2005.